Search
Cardiolipin Biosynthesis CL(a-13:0/i-22:0/24:0/a-25:0)
smpdb.ca/view/SMP0487524MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(a-15:0/i-22:0/23:0/a-25:0)
smpdb.ca/view/SMP0490166MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(a-15:0/i-24:0/25:0/a-25:0)
smpdb.ca/view/SMP0494751MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(16:0/a-21:0/i-24:0/a-25:0)
smpdb.ca/view/SMP0495535MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Rheumatoid Arthritis, Juvenile
go.drugbank.com/conditions/DBCOND0029920Drugs: Betamethasone · Celecoxib · Corticotropin · Cortisone acetate · Dexamethasone · Hydrocortisone +8 moreSynonyms: Juvenile rheumatoid a.Chills occurring with fever
go.drugbank.com/conditions/DBCOND0097433Drugs: GuaifenesinSynonyms: Has a temperatureBuprenorphine
go.drugbank.com/drugs/DB00921ApprovedIllicitInvestigationalVet approvedClinically, this results in a slow onset of action and a clinical phenomenon known as the "ceiling effect" where once a certain dose is reached, buprenorphine's effects plateau. … [L46571] Buprenorphine is commercially available as the brand name product Suboxone which is formulated in a 4:1 fixed-dose combination product along with [naloxone], a non-selective competitive opioid
Mixtures: SUBOXONE 8 MG/2 MG DILALTI TABLET, 7 ADET, Suboxone 8 mg/2 mg sublingual tabletsCategories: Drugs Used in Opioid Dependence, Drugs Used in Addictive DisordersDe Novo Triacylglycerol Biosynthesis TG(a-21:0/a-13:0/i-17:0)
smpdb.ca/view/SMP0038263MetabolicA triglyceride (TG, triacylglycerol, TAG, or triacylglyceride) is an ester derived from glycerol and three fatty acids. … Last, the enzyme diacylglycerol O-acyltransferase synthesizes triacylglycerol from diacylglycerol and a fatty acyl-CoA.
De Novo Triacylglycerol Biosynthesis TG(a-21:0/a-13:0/i-18:0)
smpdb.ca/view/SMP0038264MetabolicA triglyceride (TG, triacylglycerol, TAG, or triacylglyceride) is an ester derived from glycerol and three fatty acids. … Last, the enzyme diacylglycerol O-acyltransferase synthesizes triacylglycerol from diacylglycerol and a fatty acyl-CoA.
De Novo Triacylglycerol Biosynthesis TG(a-21:0/a-13:0/i-24:0)
smpdb.ca/view/SMP0038269MetabolicA triglyceride (TG, triacylglycerol, TAG, or triacylglyceride) is an ester derived from glycerol and three fatty acids. … Last, the enzyme diacylglycerol O-acyltransferase synthesizes triacylglycerol from diacylglycerol and a fatty acyl-CoA.